A Study of Pembrolizumab and Cryoablation in People With Mesothelioma
Clinical trial NCT05071014 · COMPLETED
Trial details
- NCT number
- NCT05071014
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-24
- Primary completion
- 2023-12-18
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.